MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION (US) 2.75/30; CORONARY DRUG-ELUTING STENT

Model Number	453963
Medical Device Problem Code	Use of Device Problem (1670)
Health Effect - Clinical Code	No Clinical Signs, Symptoms or Conditions (4582)
Date of Event	02/23/2024
Type of Reportable Event	Malfunction
Additional Manufacturer Narrative
Combination product: yes.The affected product was not returned.Therefore, no technical investigation on the subject could be performed.The production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.Review of the production documentation confirmed that the device was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.Based on the conducted review, no manufacturing related root cause could be identified.The orsiro mission (us) was used after the use by date which is indicated on the product label and warned against in the ifu.It was confirmed that the use by date was not checked prior to the device introduction, and that the physician finally decided to implant the stent.From the event description, the procedure was reported to be successful, and the device performed as intended.This indicates that the des was intact at the time of use.Due to the material characteristics and the aging behavior, there is no significant decrease in product performance including drug stability up to 3 years and therefore, no increase in risk is to be expected if the device is used 12 days after its expiration date.Also, the sterility of the orsiro mission would not be compromised if the sterile barrier was maintained until unpackaging as the same packaging and sterilization is used for products with 3 years shelf life.
Event or Problem Description
An orsiro mission drug-eluting stent, which was expired on 11-feb-2024, was successfully implanted on (b)(6) 2024 in the lad.It was noted that the staff added a red sticker, indicating the affected device was expiring soon, and it had a 2/24 sticker.Therefore, it was read off as expiring at the end of the month.When staff realized the affected device had actually expired on the 11th, it had already been introduced into the patient, and the physician made the decision to deploy.
Additional Manufacturer Narrative
Combination product: yes.Corrected the initial reporter information.Reference capa# nc-24-004.The affected product was not returned.Therefore, no technical investigation on the subject could be performed.The production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.Review of the production documentation confirmed that the device was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.Based on the conducted review, no manufacturing related root cause could be identified.The orsiro mission (us) was used after the use by date which is indicated on the product label and warned against in the ifu.It was confirmed that the use by date was not checked prior to the device introduction, and that the physician finally decided to implant the stent.From the event description, the procedure was reported to be successful, and the device performed as intended.This indicates that the des was intact at the time of use.Due to the material characteristics and the aging behavior, there is no significant decrease in product performance including drug stability up to 3 years and therefore, no increase in risk is to be expected if the device is used 12 days after its expiration date.Also, the sterility of the orsiro mission would not be compromised if the sterile barrier was maintained until unpackaging as the same packaging and sterilization is used for products with 3 years shelf life.

• Brand Name: ORSIRO MISSION (US) 2.75/30
• Common Device Name: CORONARY DRUG-ELUTING STENT
• Manufacturer (Section D): BIOTRONIK AG, BUELACH, SWITZERLAND; ackerstrasse 6; buelach CH-81 80; CH CH-8180
• Manufacturer Contact: 6024 jean road; lake oswego, OR 97035 ; 8772459800
• MDR Report Key: 18902592
• Report Number: 1028232-2024-01393
• Device Sequence Number: 7838954
• Product Code: NIQ
• UDI-Device Identifier: 07640130456198
• UDI-Public: (01)07640130456198(17)2402
• Combination Product (Y/N): Y
• Initial Reporter State: WI
• Initial Reporter Country: US
• PMA/510(K) Number: P170030
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2024
• Reporter Type: Manufacturer
• Report Source: User Facility,Company Representative
• Initial Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup
• Report Date (Section B): 10/22/2024

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 02/11/2024
• Device Model Number: 453963
• Device Catalogue Number: 453963
• Device Lot Number: 01225512
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 02/23/2024
• Supplement Date Received by Manufacturer: 10/22/2024
• Initial Report FDA Received Date: 03/14/2024
• Supplement Report FDA Received Date: 10/22/2024
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 02/11/2022
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Hospitalization
• Patient Sex: Unknown